These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 29778562)

  • 1. Comparison of tigecycline susceptibility testing methods for multidrug-resistant Acinetobacter baumannii.
    Idelevich EA; Freeborn DA; Seifert H; Becker K
    Diagn Microbiol Infect Dis; 2018 Aug; 91(4):360-362. PubMed ID: 29778562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative assessment of antimicrobial susceptibility testing for tigecycline and colistin against Acinetobacter baumannii clinical isolates, including multidrug-resistant isolates.
    Piewngam P; Kiratisin P
    Int J Antimicrob Agents; 2014 Nov; 44(5):396-401. PubMed ID: 25442358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detecting imipenem resistance in Acinetobacter baumannii by automated systems (BD Phoenix, Microscan WalkAway, Vitek 2); high error rates with Microscan WalkAway.
    Kulah C; Aktas E; Comert F; Ozlu N; Akyar I; Ankarali H
    BMC Infect Dis; 2009 Mar; 9():30. PubMed ID: 19291298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are E-test and Vitek2 good choices for tigecycline susceptibility testing when comparing broth microdilution for MDR and XDR Acinetobacter baumannii?
    Grandesso S; Sapino B; Amici G; Mazzucato S; Solinas M; Gion M
    New Microbiol; 2014 Oct; 37(4):503-8. PubMed ID: 25387287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tigecycline susceptibility of multidrug-resistant Acinetobacter baumannii from intensive care units in the western Balkans.
    Gajic I; Ranin L; Kekic D; Opavski N; Smitran A; Mijac V; Jovanovic S; Hadnadjev M; Travar M; Mijovic G
    Acta Microbiol Immunol Hung; 2020 Mar; 67(3):176-181. PubMed ID: 32160781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of VITEK 2, E-test, Kirby-Bauer disk diffusion, and modified Kirby-Bauer disk diffusion compared to reference broth microdilution for testing tigecycline susceptibility of carbapenem-resistant K. pneumoniae and A. baumannii in a multicenter study in China.
    Yin D; Guo Y; Li M; Wu W; Tang J; Liu Y; Chen F; Ni Y; Sun J; Zhang H; Zhao H; Hu F
    Eur J Clin Microbiol Infect Dis; 2021 Jun; 40(6):1149-1154. PubMed ID: 33411173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of disc diffusion, E-test, and broth microdilution methods for the determination of resistance to colistin, polymyxin B, and tigecycline in multi-resistant Acinetobacter baumannii isolates].
    Akin FE; Bayram A; Balci I
    Mikrobiyol Bul; 2010 Apr; 44(2):203-10. PubMed ID: 20549954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COMPARISON OF TWO DIFFERENT METHODS FOR TIGECYCLINE SUSCEPTIBILITY TESTING IN
    Bedenić B; Cavrić G; Vranić-Ladavac M; Barišić N; Karčić N; Tot T; Presečki-Stanko A; Lukić-Grlić A; Frančula-Zaninović S; Sreter KB
    Acta Clin Croat; 2018 Dec; 57(4):618-623. PubMed ID: 31168197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Minocycline Susceptibility Testing Methods for Carbapenem-Resistant Acinetobacter baumannii.
    Wang P; Bowler SL; Kantz SF; Mettus RT; Guo Y; McElheny CL; Doi Y
    J Clin Microbiol; 2016 Dec; 54(12):2937-2941. PubMed ID: 27629901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the Etest and broth microdilution method for tigecycline susceptibility testing against clinical isolates of Acinetobacter baumannii from Taiwan.
    Liu JW; Jang TN; Cheng YJ; Hsu GJ; Sun W; Lu CT; Hsueh PR;
    Int J Antimicrob Agents; 2010 Feb; 35(2):201-2. PubMed ID: 19892530
    [No Abstract]   [Full Text] [Related]  

  • 11. Unexpected tigecycline resistance among Acinetobacter baumannii Isolates: high minor error rate by Etest.
    Kulah C; Celebi G; Aktas E; Mengeloglu Z; Comert F; Ankarali H
    J Chemother; 2009 Aug; 21(4):390-5. PubMed ID: 19622456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High tigecycline resistance in multidrug-resistant Acinetobacter baumannii.
    Navon-Venezia S; Leavitt A; Carmeli Y
    J Antimicrob Chemother; 2007 Apr; 59(4):772-4. PubMed ID: 17353223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan.
    Liu JW; Wang LS; Cheng YJ; Hsu GJ; Lu PL; Liu YC; Chen CM; Lee CM; Sun W; Jang TN; Chiang PC; Chuang YC; Lin HC; Shi ZY; Kung HC; Huang CH; Tsao SM; Lu CT; Liao CH; Hsueh PR
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 3():S188-91. PubMed ID: 19013353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of the VITEK 2, disk diffusion, etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains.
    Lo-Ten-Foe JR; de Smet AM; Diederen BM; Kluytmans JA; van Keulen PH
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3726-30. PubMed ID: 17646414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bad bug, no test: Tigecycline susceptibility testing challenges and way forward.
    Shankar C; Pragasam AK; Veeraraghavan B; Amladi A
    Indian J Med Microbiol; 2019; 37(1):91-94. PubMed ID: 31424015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility to tigecycline of Acinetobacter baumannii strains isolated from intensive care unit patients.
    Talaga K; Krzyściak P; Bulanda M
    Anaesthesiol Intensive Ther; 2016; 48(3):166-70. PubMed ID: 27013253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Characterization of Tigecycline Non-Susceptibility among Extensively Drug-Resistant Acinetobacter baumannii Isolates of Clinical Origin.
    Haeili M; Abdollahi A; Ahmadi A; Khoshbayan A
    Chemotherapy; 2021; 66(3):99-106. PubMed ID: 33823517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of in-vitro susceptibility of multidrug-resistant Acinetobacter baumannii strains isolated from clinical specimens to tigecycline.
    Tas T; Kocoglu E; Mengeloglu Z; Bucak O; Karabörk S
    Bosn J Basic Med Sci; 2013 Nov; 13(4):266-70. PubMed ID: 24289764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of tigecycline susceptibility testing methods for expanded-spectrum cephalosporin- and carbapenem-resistant gram-negative pathogens.
    Zarkotou O; Pournaras S; Altouvas G; Pitiriga V; Tziraki M; Mamali V; Themeli-Digalaki K; Tsakris A
    J Clin Microbiol; 2012 Nov; 50(11):3747-50. PubMed ID: 22933593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan determined by the broth microdilution and disk diffusion methods.
    Liao CH; Kung HC; Hsu GJ; Lu PL; Liu YC; Chen CM; Lee CM; Sun W; Jang TN; Chiang PC; Cheng YJ; Lin HC; Shi ZY; Wang LS; Chuang YC; Tsao SM; Lu CT; Liu JW; Huang CH; Hsueh PR
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 3():S192-6. PubMed ID: 19013354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.